Sartorius Stedim Biotech S.A. (EPA:DIM)

Sartorius Stedim Biotech Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	172	426.1	678.9	116.6	107.1	223.6
Short-Term Investments	-	8.1	9.9	9.5	24.8	12.7
Cash & Short-Term Investments	172	434.2	688.8	126.1	131.9	236.3
Cash Growth	-42.42%	-36.96%	446.23%	-4.40%	-44.18%	239.49%
Accounts Receivable	266.5	192.8	265.9	293.7	404.6	356
Other Receivables	94.3	31.5	33.8	39.8	14	14.7
Receivables	360.8	227.3	300.6	334.4	419.7	371.7
Inventory	751.1	690.9	684.9	882.4	1,025	783
Other Current Assets	117.2	88.8	66.7	72.2	94.8	64.6
Total Current Assets	1,401	1,441	1,741	1,415	1,671	1,456
Property, Plant & Equipment	2,145	1,431	1,163	1,036	808	640.2
Long-Term Investments	22.3	19	24	40.8	24.9	14.8
Goodwill	2,895	2,884	2,908	2,885	1,136	820.7
Other Intangible Assets	1,483	1,231	1,361	1,465	712.1	563.3
Long-Term Deferred Tax Assets	89.9	75.2	63.2	60	61.6	46.5
Long-Term Deferred Charges	-	303.8	269	227.8	164.2	120.9
Other Long-Term Assets	3.1	598.7	727.6	601	487	289.1
Total Assets	8,039	7,984	8,256	7,730	5,065	3,951

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	288.4	277.8	310	258.5	251.5	251.4
Accrued Expenses	103.3	99.1	88.2	62.3	74.1	97.2
Current Portion of Long-Term Debt	226.2	557.3	39.5	57.7	4.5	25.5
Current Portion of Leases	25.5	23.4	25	21.4	19.5	14.9
Current Income Taxes Payable	151.3	82	123.2	189.4	209.6	165
Current Unearned Revenue	174.7	167.6	216.1	238.6	271	259.6
Other Current Liabilities	179.9	204.9	136.8	109.4	205.7	223.5
Total Current Liabilities	1,149	1,412	938.8	937.3	1,036	1,037
Long-Term Debt	1,915	1,867	2,684	3,510	1,021	521.1
Long-Term Leases	143.7	151.2	120.6	93.1	91.1	64
Pension & Post-Retirement Benefits	33.8	38.8	39.3	34.6	35.6	46.8
Long-Term Deferred Tax Liabilities	357.7	375.6	358.2	389.4	178.3	125.8
Other Long-Term Liabilities	48.7	12.9	91.3	92.2	189.7	423
Total Liabilities	3,648	3,858	4,233	5,056	2,551	2,218

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	19.5	19.5	19.5	18.4	18.4	18.4
Retained Earnings	2,934	2,703	2,496	2,391	2,179	1,397
Comprehensive Income & Other	1,424	1,368	1,471	229	251.9	240.2
Total Common Equity	4,378	4,091	3,987	2,639	2,449	1,656
Minority Interest	12.4	35.6	37.2	35.3	64.9	77.4
Shareholders' Equity	4,390	4,126	4,024	2,674	2,514	1,733
Total Liabilities & Equity	8,039	7,984	8,256	7,730	5,065	3,951

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	2,310	2,599	2,870	3,682	1,136	625.5
Net Cash (Debt)	-2,138	-2,165	-2,181	-3,556	-1,004	-389.2
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-21.99	-22.25	-22.53	-38.58	-10.89	-4.22
Filing Date Shares Outstanding	97.45	97.3	97.3	92.16	92.16	92.18
Total Common Shares Outstanding	97.45	97.3	97.3	92.16	92.16	92.18
Working Capital	251.8	29.1	802.2	477.8	635.3	418.5
Book Value Per Share	44.93	42.04	40.97	28.63	26.58	17.96
Tangible Book Value	0.6	-24.7	-282.4	-1,711	600.8	271.9
Tangible Book Value Per Share	0.01	-0.25	-2.90	-18.57	6.52	2.95
Land	-	1,023	803.1	707.8	509.1	426.2
Machinery	-	895.6	796.2	688.5	581.3	469.7
Order Backlog	-	1,308	1,482	1,495	1,844	1,915

Data Source: S&P Global Market Intelligence Last updated: Oct 22, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 8, 2026

Data Sources Report a data error